|
Roche Diagnostics Recognized For Its Innovation, Product Design
and Leadership in Diabetes Care Technology in 2002
Basel, Switz. - January 20, 2003 - For more than 25 years,
Roche Diagnostics has been a pioneer and leader in the development
of blood glucose monitoring systems. The company's commitment to
make living with diabetes easier was acknowledged as numerous European
and US organizations recognized Roche for its continued dedication
to innovation, design and leadership in diabetes care technology.
Roche received the following awards in 2002: The Design Business
Association (UK) and The Chicago Athenaeum Good Design Award (US)
for Accu-Chek Inform; The US National Association of Chain Drug
Stores (NACDS) and Canon Communications LLC best product in home
healthcare and medical design award and The Medical Design Excellence
Award for Accu-Chek Compact; and several E-Healthcare/ Leadership
Awards (US).
Accu-Chek Inform
The Chicago Athenaeum: Museum of Architecture and Design, announced
that Roche Diagnostics and Kinneir Dufort received the Good Design
award in the medical equipment category for its Accu-Chek Inform.
Founded in 1950, Good Design is the world's oldest and most celebrated
awards program that bestows international recognition upon designers
and manufacturers for advancing new and innovative product concepts
and originality.
The Good Design Award was announced just one month after the company
received a prestigious award from the UK Design Business Association
for the design and commercial effectiveness of the Accu-Chek Inform.
The main requisite to achieve this award is proven sales growth
by superior product design.
Accu-Chek Compact
The US National Association of Chain Drug Stores (NACDS) and Canon
Communications LLC awarded Roche Diagnostics for the best product
in home healthcare and medical design for its integrated blood glucose
monitoring system - the Accu-Chek Compact System.
The Accu-Chek Compact System integrates multiple features into
a single system. The Accu-Chek Compact System being "the one
with the drum™," eliminates the need to handle test strips
and code keys. The automatic coding and the integrated test strips
allow for easier and safer handling.
Roche Diagnostics also was named a gold winner at the Medical Design
Excellence Awards Competition, sponsored by Canon Communications
LLC, during the Medical Design and Manufacturing East (MDEA) 2002
Conference and Exposition in New York City. This award recognizes
products for innovation, design and engineering excellence, end-user
and patient benefits, and cost-effectiveness in manufacturing and
the healthcare industry. MDEA is the only awards program that exclusively
recognizes contributions and advances in the design of medical products.
E-Healthcare and Excellence in Healthcare
Roche Diagnostics E-Business unit received nine awards during the
Healthcare Internet & Technology conference for leading the
industry in e-healthcare strategies. The website, Accu-Chek.com,
won silver awards for best site content and best site design. Other
awards included: CEO Commitment to Healthcare, overall Internet
site, e-Business strategy and interactivity. Sites receiving the
2002 e-Healthcare Leadership Awards were selected from more than
1,000 entries.
Additionally, Frost & Sullivan, a global leader in strategic
market training and growth consulting, honored Roche Diagnostics
Corporation, the center of the North American headquarters for the
diagnostics and diabetes business, with the presentation of three
prominent awards: The Company of the Year, Market Engineering Leadership
and CEO of the Year.
"The Frost and Sullivan and E-Healthcare awards are an honor
because they are a testimony to our innovative and talented people,"
said Martin Madaus, President and CEO of Roche Diagnostics, North
America. "Our culture and commitment to developing products
and services that make living with diabetes easier, drives us to
do our very best for our customers.
About Roche and Roche Diagnostics
Headquartered in Basel, Switzerland, Roche is one of the world's
leading research-oriented healthcare groups. The company's two core
businesses in pharmaceuticals and diagnostics provide innovative
products and services that address prevention, diagnosis and treatment
of diseases, thus enhancing people's health and quality of life.
The two core businesses achieved sales of 19.3 billion Swiss Francs
in the first three quarters of 2002 and employed about 57,000 employees
worldwide. Roche's Diagnostics Division, the world leader in in-vitro
diagnostics with a uniquely broad product portfolio, supplies a
wide array of innovative testing products and services to researchers,
physicians, patients, hospitals and laboratories world-wide. As
a leader in diabetes management technology, Roche Diagnostics is
dedicated to developing technologies and services under the Accu-Chek
brand, that helps making living with diabetes easier. For further
information, please visit our websites www.roche.com
and www.roche-diagnostics.com.
Accu-Chek, Accu-Chek Compact and Accu-Chek Inform are trademarks
of a member of the Roche Group.
|
